- Home
- ACRV vs BDL Comparison
ACRV vs BDL Comparison
Compare ACRV & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- BDL
- Stock Information
- Founded
- ACRV 2018
- BDL 1959
- Country
- ACRV United States
- BDL United States
- Employees
- ACRV N/A
- BDL N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- BDL Restaurants
- Sector
- ACRV Health Care
- BDL Consumer Discretionary
- Exchange
- ACRV Nasdaq
- BDL Nasdaq
- Market Cap
- ACRV 47.8M
- BDL 52.7M
- IPO Year
- ACRV 2022
- BDL N/A
- Fundamental
- Price
- ACRV $2.09
- BDL $31.84
- Analyst Decision
- ACRV Buy
- BDL
- Analyst Count
- ACRV 6
- BDL 0
- Target Price
- ACRV $17.75
- BDL N/A
- AVG Volume (30 Days)
- ACRV 464.1K
- BDL 2.4K
- Earning Date
- ACRV 11-12-2025
- BDL 08-12-2025
- Dividend Yield
- ACRV N/A
- BDL 1.73%
- EPS Growth
- ACRV N/A
- BDL 41.91
- EPS
- ACRV N/A
- BDL 2.32
- Revenue
- ACRV N/A
- BDL $201,851,000.00
- Revenue This Year
- ACRV N/A
- BDL N/A
- Revenue Next Year
- ACRV $805.34
- BDL N/A
- P/E Ratio
- ACRV N/A
- BDL $13.70
- Revenue Growth
- ACRV N/A
- BDL 8.84
- 52 Week Low
- ACRV $1.05
- BDL $22.61
- 52 Week High
- ACRV $8.74
- BDL $35.98
- Technical
- Relative Strength Index (RSI)
- ACRV 65.95
- BDL 52.24
- Support Level
- ACRV $1.92
- BDL $30.23
- Resistance Level
- ACRV $2.05
- BDL $32.90
- Average True Range (ATR)
- ACRV 0.15
- BDL 1.11
- MACD
- ACRV 0.01
- BDL -0.03
- Stochastic Oscillator
- ACRV 97.70
- BDL 60.51
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.